Peptide safety cannot be answered for an entire class of substances. Risks depend on the particular product, a person’s medical history, interactions and the quality of the available evidence.
Laboratory and animal studies do not establish human safety. Small or short studies may miss uncommon adverse effects or long-term risks. Evidence for a registered medicine cannot be transferred to an experimental compound.
Pregnancy, breastfeeding, cancer history, organ disease and current medicines are important topics for clinical review. A website cannot determine whether a treatment suits an individual.
An offshore research-only product may have unverified identity, purity or sterility. A disclaimer on a seller’s website does not resolve those risks or Australian import restrictions.
Discuss unexpected symptoms with a health practitioner. Severe symptoms, breathing difficulty or collapse require urgent medical care; in an emergency call 000. No medicine is free of risk.
Claims about peptides often come from sellers, social media or forums rather than from regulators or published research. A useful first check is whether a product is on the Australian Register of Therapeutic Goods. If it isn't, the TGA has not assessed its safety, quality or effectiveness, whatever the label or website says.
The TGA has issued safety warnings about unapproved peptide products sold online, including products labelled for research use. It has received reports of serious adverse events, such as severe allergic reactions, and notes that the contents of these products may not match their labels. healthdirect gives similar guidance for consumers.
Useful questions for a doctor include: Is there an approved option for my situation? What is known, and not known, about long-term effects? How would side effects be monitored, and when should I seek help? Could this interact with my current medicines or conditions? What happens if I decide not to go ahead?
If you think a medicine or other therapeutic product has caused a side effect, tell your doctor or pharmacist. You can also report it directly to the TGA. Reports help regulators identify safety problems that clinical studies may have missed.
The TGA, healthdirect and your own GP or pharmacist are better starting points than seller websites. The healthdirect helpline, 1800 022 222, offers health advice at any time of day.
Some groups face higher or less well understood risks. These include people who are pregnant, breastfeeding or planning a pregnancy, people with a history of cancer, people with heart, kidney or liver conditions, and anyone taking several regular medicines. Competitive athletes also need to consider anti-doping rules. Being in one of these groups doesn't settle the question on its own, but it is important information for a doctor to have before any treatment is discussed. Bringing a list of your current medicines, supplements and recent test reports to a consultation helps the doctor give advice that fits your situation.